A detailed history of Fifth Third Bancorp transactions in Dexcom Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 25,794 shares of DXCM stock, worth $1.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,794
Previous 27,341 5.66%
Holding current value
$1.96 Million
Previous $3.1 Million 44.24%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$64.0 - $116.06 $99,008 - $179,544
-1,547 Reduced 5.66%
25,794 $1.73 Million
Q2 2024

Jul 22, 2024

SELL
$110.31 - $140.45 $360,051 - $458,428
-3,264 Reduced 10.66%
27,341 $3.1 Million
Q1 2024

Apr 23, 2024

BUY
$114.22 - $140.1 $591,202 - $725,157
5,176 Added 20.35%
30,605 $4.24 Million
Q4 2023

Jan 19, 2024

BUY
$75.49 - $124.16 $218,468 - $359,319
2,894 Added 12.84%
25,429 $3.16 Million
Q3 2023

Oct 31, 2023

SELL
$86.06 - $137.93 $60,328 - $96,688
-701 Reduced 3.02%
22,535 $2.1 Million
Q2 2023

Jul 25, 2023

BUY
$112.47 - $130.98 $787,514 - $917,121
7,002 Added 43.13%
23,236 $2.99 Million
Q1 2023

Apr 24, 2023

SELL
$104.0 - $122.92 $34,736 - $41,055
-334 Reduced 2.02%
16,234 $1.89 Million
Q4 2022

Jan 25, 2023

BUY
$84.98 - $122.67 $106,225 - $153,337
1,250 Added 8.16%
16,568 $0
Q3 2022

Oct 25, 2022

BUY
$76.35 - $94.18 $156,746 - $193,351
2,053 Added 15.48%
15,318 $1.23 Million
Q2 2022

Aug 04, 2022

BUY
$67.99 - $132.89 $661,066 - $1.29 Million
9,723 Added 274.51%
13,265 $989,000
Q1 2022

Apr 19, 2022

SELL
$94.08 - $130.2 $104,240 - $144,261
-1,108 Reduced 23.83%
3,542 $1.81 Million
Q4 2021

Feb 01, 2022

BUY
$129.87 - $162.82 $240,389 - $301,379
1,851 Added 66.13%
4,650 $2.5 Million
Q3 2021

Oct 15, 2021

BUY
$106.71 - $143.18 $41,723 - $55,983
391 Added 16.24%
2,799 $1.53 Million
Q2 2021

Aug 06, 2021

BUY
$80.99 - $107.93 $21,057 - $28,061
260 Added 12.1%
2,408 $1.03 Million
Q1 2021

May 07, 2021

BUY
$84.79 - $104.74 $56,046 - $69,233
661 Added 44.45%
2,148 $772,000
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $3,432 - $4,598
44 Added 3.05%
1,487 $550,000
Q3 2020

Nov 09, 2020

BUY
$95.51 - $112.95 $6,208 - $7,341
65 Added 4.72%
1,443 $595,000
Q2 2020

Aug 05, 2020

BUY
$62.68 - $105.34 $6,079 - $10,217
97 Added 7.57%
1,378 $559,000
Q1 2020

May 05, 2020

BUY
$47.79 - $75.63 $13,333 - $21,100
279 Added 27.84%
1,281 $345,000
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $878 - $1,374
24 Added 2.45%
1,002 $219,000
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $4,974 - $6,132
140 Added 16.71%
978 $146,000
Q2 2019

Aug 07, 2019

BUY
$27.84 - $38.92 $5,707 - $7,978
205 Added 32.39%
838 $126,000
Q1 2019

May 14, 2019

BUY
$28.07 - $38.18 $17,768 - $24,167
633 New
633 $75,000
Q3 2017

Nov 14, 2017

SELL
$11.36 - $18.98 $2,930 - $4,896
-258 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
258
258 $19,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.